Plain-English translation of NCT07373353 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This clinical trial is testing the safety and effectiveness of AMJ-401, a special heart stent coated with a medication called everolimus that is designed to dissolve gradually over time. The stent is placed during a minimally invasive procedure to open blocked arteries in the heart. Researchers want to see if this dissolving stent works as well as traditional stents while potentially reducing long-term complications.
Traditional metal stents remain in your arteries permanently, which can sometimes cause problems years later. This medication is designed to open the blocked artery and then safely dissolve, potentially giving your artery a better chance to heal naturally over time.
You likely qualify if…
You likely don't qualify if…
You will undergo a catheter procedure where doctors thread a thin tube through your blood vessels and place the new stent in your blocked coronary artery or arteries. After the procedure, you will take two blood-thinning medications daily for at least 12 months and attend follow-up visits so researchers can monitor your heart health and how well the stent is working. The study lasts about 13 months total, during which you cannot enroll in any other investigational medical studies.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Japan